altretamine and cb 10375

altretamine has been researched along with cb 10375 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Abel, G; Graham, MA; Judson, IR; Rutty, CJ1
Abel, G; Goddard, PM; Harrap, KR; Judson, IR; Newell, DR; Rutty, CJ1
Boven, E; Erkelens, CA; Nauta, MM; Pinedo, HM; Schlüper, HM1
Brooks, N; Coley, HM; Hewer, A; Jarman, M; Jenkins, TC; Judson, IR; Phillips, DH1
Coley, HM1

Reviews

1 review(s) available for altretamine and cb 10375

ArticleYear
N-(Hydroxymethyl) melamines.
    General pharmacology, 1997, Volume: 28, Issue:2

    Topics: Altretamine; Animals; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Neoplasms; Triazines

1997

Other Studies

5 other study(ies) available for altretamine and cb 10375

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Low central nervous system penetration of N2,N4,N6,-trihydroxymethyl-N2,N4,N6,-trimethylmelamine (Trimelamol): a cytotoxic s-triazine with reduced neurotoxicity.
    British journal of cancer, 1986, Volume: 53, Issue:5

    Topics: Altretamine; Animals; Blood Proteins; Blood-Brain Barrier; Brain; Kinetics; Male; Mice; Mice, Inbred BALB C; Protein Binding; Triazines

1986
Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activation.
    Cancer chemotherapy and pharmacology, 1986, Volume: 17, Issue:3

    Topics: Altretamine; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Kinetics; Male; Mice; Mice, Inbred BALB C; Plasmacytoma; Rats; Rats, Inbred Strains; Solubility; Triazines

1986
Superior efficacy of trimelamol to hexamethylmelamine in human ovarian cancer xenografts.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18, Issue:2

    Topics: Altretamine; Animals; Antineoplastic Agents; Female; Humans; Kinetics; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Transplantation, Heterologous; Triazines

1986
The role of the N-(hydroxymethyl)melamines as antitumour agents: mechanism of action studies.
    Biochemical pharmacology, 1995, May-11, Volume: 49, Issue:9

    Topics: Alkylating Agents; Altretamine; Animals; Antineoplastic Agents; Cell Line; Cross-Linking Reagents; Flow Cytometry; Formaldehyde; Humans; Triazines

1995